Riyadh – Sharikat Mubasher: Supported by the Saudi Ministry of Health, "Convention on Pharmaceutical Ingredients" CPHI, the premier pharma event in the region, kicked off today, taking place from 10 to 12 of December at the Riyadh International Convention & Exhibition Center, Riyadh, Saudi Arabia.
The event is expected to welcome over 400 exhibitors from more than 100 states, with over 150 speakers from top-notch experts within the local and global pharmaceutical industry.
The 2024 show will feature a group of the top industry leaders from across the world presenting data-driven, evidence-based solutions, the latest research, ingredient insights, innovations, and formulation strategies.
CPHI Middle East aims to attract global suppliers of raw materials, machinery, packaging solutions, and contract services and connect them with regional visitors, suppliers, and production partners offering a huge business potential.
During the first day of the Conference, Fahad bin Abdurrahman Al-Jalajel, Minister of Health, witnessed the signing of multiple agreements worth nearly SAR 10 billion, in addition to announcing several partnerships including one with Tamer Group worth SAR 1.5 billion, and Tabuk Pharmaceuticals worth SAR 100 million.
Hosting this event reflects the Kingdom’s leading role in health and pharmaceutical fields, highlighting the huge efforts it exerts to address current and future major challenges in the industry in the context of Vision 2030.
